|
BR122021024397A2
(enExample)
|
|
|
|
BR122021000189A2
(enExample)
|
|
|
|
BR112020006084A8
(enExample)
|
|
|
|
BR122022025811B8
(enExample)
|
|
|
|
BR202018014992U2
(enExample)
|
|
|
|
BR122022008542B1
(pt)
|
|
Uso de um composto e composição farmacêutica o compreendendo
|
|
BR122021023687A2
(enExample)
|
|
|
|
BR122021014832A2
(enExample)
|
|
|
|
BR122022003518A2
(enExample)
|
|
|
|
BR112020008820A2
(enExample)
|
|
|
|
BR202017025154U2
(enExample)
|
|
|
|
BR202017021228U2
(enExample)
|
|
|
|
BR202017020981U2
(enExample)
|
|
|
|
BE2017C035I2
(enExample)
|
|
|
|
BR202017017068U2
(enExample)
|
|
|
|
BR202017016984U2
(enExample)
|
|
|
|
BR202017016924U2
(enExample)
|
|
|
|
BR102017015495A2
(enExample)
|
|
|
|
BR102017015250A2
(enExample)
|
|
|
|
BR102017014430A2
(enExample)
|
|
|
|
BR102017003115A2
(enExample)
|
|
|
|
BR202017002937U2
(enExample)
|
|
|
|
BR202017002826U2
(enExample)
|
|
|
|
CN304002110S
(enExample)
|
|
|
|
CN303863459S9
(enExample)
|
|
|